Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Stockport, United Kingdom Clinical Trials

A listing of Stockport, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (6) clinical trials

Analysis of Patient Outcome Questionnaire Following Primary Knee Replacement

Knee osteoarthritis (OA) is a major cause of disability around the world; it is the most common chronic condition in primary care in the UK. By 2030 it is predicted to be the greatest cause of disability in the general population. An effective end-stage treatment for knee OA is knee-replacement ...

Phase N/A

0.69 miles

Learn More »

DermaRep Device in the Treatment of Venous Leg Ulcers

This is a First in Human clinical study on the safety and effectiveness of DermaRep wound contact dressing. Patients with venous leg ulcers will be treated with standard of care dressings and compression for 4 weeks to establish a baseline wound healing response. All patients will then be treated with ...

Phase N/A

6.2 miles

Learn More »

An Approach to "Move a Little & Often" With Health Conditions

There is a growing focus in research on the need to reduce sedentary behaviours. Studies have shown that independently of moderate to vigorous physical activity, the amount of time spent sedentary predicts poorer health outcomes. This means that in addition to exercising, it is important to reduce prolonged periods of ...

Phase N/A

6.72 miles

Learn More »

Mobile Electronic Devices for Visual Impairment

By converting text into speech and being cheaply and readily available, smartphones and tablets offer a completely new type of assistive technology for visually-impaired people (VIP). Research on these mobile electronic devices (MED) is relevant to rehabilitation and enablement of individuals with all types of visual impairment, with all degrees ...

Phase N/A

6.72 miles

Learn More »

A Study to Investigate Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD

CHF6297 is a potent and selective inhibitor of human MAP kinase p38 being developed as an anti-inflammatory agent for the treatment of inflammatory airways diseases. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat doses of CHF6297 as dry powder formulation ...

Phase

6.8 miles

Learn More »

Effectiveness and Cost-effectiveness of a Tailored Text Message Programme (MiQuit) for Smoking Cessation in Pregnancy

Smoking in pregnancy is expensive; in the UK in 2010 the annual smoking-attributable maternal and infant health care costs were estimated at up to 87.5 million. In high income countries 13% to 25% of pregnant women smoke and rates are increasing in developing ones. In the UK in 2010 26% ...

Phase N/A

9.16 miles

Learn More »